Ayala Pharmaceuticals Inc (ADXS)

[bill_y]

adxs has seen its value plummet despite big pharma partners, successful trials with several constructs for different cancer types and a p3 trial for hpv cervical ongoing which has orphan status from fda, as well as fast track in US and EU..seems like a conspiracy against immune therapy..and 500 million partnership with amgen and 300 million with celene + 10 million from stenhal a latin american distributor to pay phase 3 costs. go figure.only 40 million os and 80 million in bank ..plus some other interesting tidbits like imminent approval of pet vaccine for osteoscarcoma and ema filing in uk. a mrket cap of 120 million..insane market folks. shares are hard to find and shorts know they can control and cover once market adjusts share demand,but until then ...